SOPHARMA (SPH): Conclusion of transactions from the scope of art. 114, para. 2 of the LPOS - raport 1
Raport ESPI
UNI - EN REPORT No
1
/
2022
UNI - EN REPORT No1/2022
Sofia, Bulgaria, January 6, 2022 – According to the requirements of Art. 100t of LPOS and in connection with Art. 114, para. 9 of the Law on Public Offering of Securities, “Sopharma” AD (SFA: BSE-Sofia, SPH: Warsaw Stock Exchange) announces that today, according to a decision of the Board of Directors dated December 21, 2021, the company concluded the following transactions falling within the scope of Art. 114, para. 2 of the LPOS:
